2021
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV
Wyse JJ, McGinnis KA, Edelman EJ, Gordon AJ, Manhapra A, Fiellin DA, Moore BA, Korthuis PT, Kennedy AJ, Oldfield BJ, Gaither JR, Gordon KS, Skanderson M, Barry DT, Bryant K, Crystal S, Justice AC, Kraemer KL. Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV. AIDS And Behavior 2021, 26: 975-985. PMID: 34495424, PMCID: PMC8840957, DOI: 10.1007/s10461-021-03452-0.Peer-Reviewed Original ResearchConceptsOpioid agonist therapyOpioid use disorderVeterans Aging Cohort StudyHIV statusUse disordersOpioid agonist treatmentAging Cohort StudyDiagnosis of HCVTwelve-month retentionPositive health outcomesOAT retentionAgonist therapyCohort studyHIV managementAgonist treatmentPredictors of retentionPatientsHealth outcomesHistory of homelessnessHIVLower likelihoodImproved likelihoodLikelihood of initiationBuprenorphineDisorders
2016
National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012
Gaither JR, Leventhal JM, Ryan SA, Camenga DR. National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012. JAMA Pediatrics 2016, 170: 1195-1201. PMID: 27802492, PMCID: PMC7245935, DOI: 10.1001/jamapediatrics.2016.2154.Peer-Reviewed Original ResearchConceptsOpioid poisoningInpatient DatabaseAge groupsSerial cross-sectional dataDischarge recordsPrescription opioid poisoningsOpioid prescribing practicesHospital discharge recordsKids' Inpatient DatabaseCharacteristics of hospitalizationsYears of ageCochran-Armitage testPediatric hospital discharge recordsOpioid exposureAnnual incidencePediatric populationPrescription opioidsNinth RevisionPrescribing practicesChildren 1Opioid storageClinical ModificationRetrospective analysisHospitalizationMAIN OUTCOME